Results 191 to 199 of about 36,274 (199)

Visceral and subcutaneous fat attenuation as prognostic indicators of survival in castration resistant prostate cancer. [PDF]

Prostate Int
Heo JE, Han HH, Jang WS, Lee SH, Ham WS, Han WK, Choi YD, Lee J.   +7 more
europepmc   +1 more source

The pterocarpan (+)-PTC modulates cytoskeletal proteins and induces apoptosis in metastatic castration-resistant prostate cancer: a proteomic perspective. [PDF]

Front Pharmacol
de Brito Vieira Neto J, Moraes de Farias K, Alves Sales SL, Melo VB, Nascimento Macêdo SM, Koscky Paier CR, Bezerra MJ, Moura AA, Carvalho HF, Domingos de Sousa F, Aquino A, de Oliveira Monteiro AC, Martins-de-Souza D, Banwell MG, Miranda Furtado CL, Pessoa C.   +15 more
europepmc   +1 more source

Rethinking combination strategies in metastatic castration-resistant prostate cancer (mCRPC)-lessons from KEYNOTE-641. [PDF]

Transl Androl Urol
Nguyen MD, Vinh-Hung V, Verschraegen C, Wang P.   +3 more
europepmc   +1 more source

Bellmunt Risk Score as a Prognostic Tool in Metastatic Castration-Resistant Prostate Cancer Survival.

JAMA Netw Open
Büttner T, Klümper N, Ellinger J, Ritter M, Krausewitz P.   +4 more
europepmc   +1 more source

From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer. [PDF]

Drugs Real World Outcomes
Bosch D, van der Velden KJM, Beeker A, van den Berg HP, Bergman AM, van der Doelen MJ, van den Eertwegh AJM, Hendriks MP, Kerkhofs TMA, van de Luijtgaarden ACM, Mehra N, van Moorselaar RJA, Tascilar M, Vervenne WL, Weijl NI, Uyl-de Groot CA, Mulders PFA, Kuppen MCP, van Oort IM.   +18 more
europepmc   +1 more source

A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer. [PDF]

Oncologist
Graff JN, Smith CEP, Sokolova AO, Qian DZ, Beer TM, Latour E, Bailey S, Kreitner D, Grivas P, Schweizer MT, Higano CS, Alumkal JJ, Vuky J, Yu EY, Cheng HH.   +14 more
europepmc   +1 more source

Quercetin Inhibits AKT Ser473 Phosphorylation and Disrupts AKT-Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Cells. [PDF]

Antioxidants (Basel)
Duprat F, Azócar-Plaza S, Castillo-Cáceres MP, Rivas Y, Sanzana-Rosas J, Pampaloni P, Olivas-Henríquez G, Toledo J, Villa JL, Bertinat R, Jara N, Vallejos-Almirall A, Salas A, González-Chavarría I.   +13 more
europepmc   +1 more source

Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer.

JAMA Netw Open
Barata PC, Corrigan JK, La J, Culnan JM, Akama-Garren E, Dulberger KN, Dumontier C, Hansen J, Bihn JR, Bitting RL, Brophy MT, Cheng HH, Cooperberg MR, Do NV, Dorff T, Fojo AT, Gaziano JM, Goryachev SD, Halabi S, Hauger RL, Nanus DM, Rebbeck TR, Pan CX, Schoen MW, Swinnerton KN, Myrie K, Ramoni RB, Fillmore NR, Paller CJ, Rettig MB.   +29 more
europepmc   +1 more source